{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-8286", "FDA", "Request that the FDA determine whether DDAVP (desmopressin acetate) Nasal Spray, 0.01 mg/Spray (Needs No Refrigeration), Product No. 003 approved under New Drug Application (NDA) number 017922, held by Ferring Pharmaceuticals, Inc., has been voluntarily withdrawn for reasons of safety or effectiveness.", "Nonrulemaking", "2026-09-15T20:37:09Z", "0b000064b93d1750", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-8286"], "units": {}, "query_ms": 0.30492106452584267, "source": "U.S. government sources, plus a few identifier registries; each is listed on the methodology page", "source_url": "https://datadawn.org/methodology#data", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}